Purchase of emulate chip-S1 basic research kits
Ended Purchase Order Awarded
- Contract number
- 75F40125P00270
- Awardee
-
Emulate Inc. UEI RPUADLQ52GD7
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $248,000
Award facts
- Contract value 100% obligated
- $248,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AJ12 General Science And Technology R&D Services; General Science And Technology; Applied Research
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a $248,000 firm fixed price purchase order to Emulate Inc. for Emulate Chip-S1 Basic Research Kits on September 19, 2025. The contract, with an ultimate completion date of September 18, 2026, will be performed at the FDA's Silver Spring, Maryland location. No set-aside designation was applied to this procurement. Emulate Inc., headquartered in Boston, Massachusetts, is a biotechnology company specializing in organ-on-chip microphysiological systems that replicate human organ functions to support advanced research and regulatory science initiatives.
This purchase order reflects the FDA's continued investment in Emulate's organ-on-chip technology as part of the agency's broader efforts to develop alternatives to traditional animal testing and advance preclinical drug development screening methods. The Chip-S1 Basic Research Kits align with the FDA's regulatory science objectives and complement the agency's existing cooperative agreement with Emulate focused on Liver-Chip technology for predicting drug-induced liver injury risk. As a civilian contracting agency within the Department of Health and Human Services, the FDA has established Emulate as a key vendor for providing innovative bioengineered systems that enable more accurate human biology modeling across multiple federal research institutions.
Quick answers
Who was awarded contract 75F40125P00270?
75F40125P00270 was awarded to Emulate Inc. by Food and Drug Administration (Department of Health and Human Services) on September 19, 2025.
How much is contract 75F40125P00270 worth?
The government has obligated $248,000 on 75F40125P00270.
Was contract 75F40125P00270 competed?
The extent of competition for 75F40125P00270 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award